The effects of cardiac rehabilitation in patients with chest pain after coronary stenting

To evaluate the effects of cardiac rehabilitation in patients with recurrence of symptoms after percutaneous coronary intervention (coronary stenting)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015042421921N1

Enrollment

Registered

2015-06-01

Start date

2015-03-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrence of symptoms after percutaneous coronary intervention. presence of coronary angioplasty implant and graft

Interventions

Intervention 1: The intervention group receives cardiac rehabilitation three times a week for twenty sessions.Each session begins with 5 minutes warm up and stretching exercises and proceeds with inte

Rehabilitation

The intervention group receives cardiac rehabilitation three times a week for twenty sessions.Each session begins with 5 minutes warm up and stretching exercises and proceeds with intermittent interva

The control group receives no intervention and continues their routine medications and daily activities without any change.

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The age of forty to seventy years; patients with coronary artery disease that coronary stenting was done for them; recurrence of symptoms (angina or dyspnea) at any time after coronary stenting; ejection fraction: 35% or more; primary stenting. Exclusion criteria: history of coronary artery bypass graft surgery (CABG); functional class 4 according the New York Heart Association(NYHA); severe valvular heart disease; arrhythmia except atrial fibrillation (without rapid ventricular response); uncontrolled hypertension(systolic blood pressure more than 200 mmHg or diastolic blood pressure more than 120 mmHg); uncontrolled diabetes mellitus or thyroid disease; recent myocardial infarction or unstable angina pectoris; exercise limitation due to neuromuscular, musculoskeletal or mental diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Functional capacity. Timepoint: at the beginning of the study and after 2 months. Method of measurement: distance walked on the 6 min walk test( in meters ).;Maximal exrcise capacity. Timepoint: at the beginning of the study and after 2 months. Method of measurement: maximum workload tolerated by the patient on the ramp test(in watts).	—

Secondary

Measure	Time frame
Quality of life. Timepoint: at the beginning of the study and after 2 months. Method of measurement: Quality of Life SF-36 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Roshanaei

Shiraz University of Medical Sciences

roshanaei@sums.ac.ir+98 71 3627 7156

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026